Диссертация (1103954), страница 34
Текст из файла (страница 34)
J. Kastrup, B. L. JohnsonKerner, et al. // J. Am. Chem. Soc. — 2008. — Vol. 130, no. 11. — P. 3458–3464.[48] Panteleev, M. A. Spatial propagation and localization of blood coagulation are regulatedby intrinsic and protein C pathways, respectively / M. A. Panteleev, M. V. Ovanesov,D. A. Kireev, et al. // Biophys. J. — 2006. — Vol. 90, no. 5. — P. 1489–1500.174[49] Hemker, H. C.
Platelet membrane involvement in blood coagulation / H. C. Hemker,J. L. van Rijn, J. Rosing, et al. // Blood cells. — 1983. — Vol. 9, no. 2. — P. 303–317.[50] Monroe, D. M. Platelets and thrombin generation / D. M. Monroe, M. Hoffman,H. R. Roberts // Arterioscler.
Thromb. Vasc. Biol. — 2002. — Vol. 22, no. 9. —P. 1381–1389.[51] Sinauridze, E. I. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets / E. I. Sinauridze, D. A. Kireev, N. Y. Popenko,et al. // Thromb. Haemost. — 2007. — Vol. 97. — P.
425–434.[52] Bolton-Maggs, P. H. Inheritance and bleeding in factor XI deficiency / P. H. Bolton-Maggs,B. Young Wan-Yin, A. H. McCraw, et al. // Br. J. Haematol. — 1988. — Vol. 69. —P. 521–528.[53] Ragni, M. Comparison factor of bleeding tendency, factor XI coagulant activity, and factorXI antigen in 25 factor XI-deficient kindreds / M. Ragni, F.
Sinha, F. Seaman, et al. //Blood. — 1985. — Vol. 65, no. 3. — P. 719–724.[54] Meijers, J. High levels of coagulation factor XI as a risk factor for venous thrombosis /J. Meijers, W. Tekelenburg, B. Bouma, et al. // N. Engl. J. Med. — 2000. — Vol. 342,no. 10. — P.
696–701.[55] Berliner, J. I. Elevated levels of Factor XI are associated with cardiovascular disease inwomen / J. I. Berliner, A. C. Rybicki, R. C. Kaplan, et al. // Thromb. Res. — 2002. —Vol. 107, no. 1-2. — P. 55–60.[56] Panteleev, M. A. Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation / M. A. Panteleev, A. N.
Balandina, E. N. Lipets, et al. //Biophys. J. — 2010. — Vol. 98, no. 9. — P. 1751–1761.[57] Dreyfus, M. Treatment of homozygous protein C deficiency and neonatal purpura fulminanswith a purified protein C concentrate / M. Dreyfus, J. F. Magny, F. Bridey, et al.
// N.Engl. J. Med. — 1991. — Vol. 325. — P. 1565–1568.[58] Lane, D. A. Inherited thrombophilia: part 1 / D. A. Lane, P. M. Mannucci, K. A. Bauer,et al. // Thromb. Haemost. — 1996. — Vol. 76. — P. 651–662.[59] Lane, D. A. Inherited thrombophilia: part 2 / D. A. Lane, P. M. Mannucci, K. A. Bauer,et al. // Thromb. Haemost. — 1996. — Vol. 76. — P. 824–834.175[60] Rosenberg, R.
D. Regulation of the hemostatic mechanism / R. D. Rosenberg // Mol. BasisBlood Dis. / Ed. by G. Stamatoyannopoulos, A. W. Nienhuis, P. Leder, P. W. Majerus. —Philadelphia, PA : 1987. — P. 534–574.[61] Pabinger, I. Hereditary deficiency of antithrombin III, protein C and protein S: prevalencein patients with a history of venous thrombosis and criteria for rational patient screening /I. Pabinger, S. Brucker, P. A. Kyrle, et al.
// Blood Coagul. Fibrinolysis. — 1992. —Vol. 3. — P. 547–553.[62] Rezaie, A. R. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction bya template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparinbinding to factor Xa / A. R. Rezaie // J. Biol. — 1998. — Vol.
273. — P. 16824–16827.[63] Esmon, C. T. The Protein C Pathway / C. T. Esmon // Chest. — 2003. — Vol. 124. —P. 26–32.[64] Чуличков, А. Л. Пороговая активация свертывания крови и рост тромба в условияхкровотока / А. Л. Чуличков, А. В. Николаев, А. И. Лобанов, Г. Т. Гурия // Матем.моделирование. — 2000. — Т. 12, № 3. — С. 75–96.[65] Kastrup, C.
J. Modular chemical mechanism predicts spatiotemporal dynamics of initiationin the complex network of hemostasis / C. J. Kastrup, M. K. Runyon, F. Shen, R. F. Ismagilov // Proc. Natl. Acad. Sci. USA. — 2006. — Vol. 103, no. 43. — P. 15747–15752.[66] Kastrup, Ch. J. Spatial localization of bacteria controls coagulation of human blood by’quorum acting’ / Ch. J. Kastrup, J. Q. Boedicker, A. P. Pomerantsev, et al. // NatureChem. Biol. — 2008.
— Vol. 4, no. 12. — P. 742–750.[67] Zwaal, R. F. A. Blood coagulation / R. F. A. Zwaal, H. C. Hemker. — Elsevier edition. —1986.[68] Davie, E W. A brief historical review of the waterfall cascade of blood coagulation. /E W Davie // J. Biol. Chem.
— 2003. — Vol. 278, no. 51. — P. 50819–50832.[69] Broze, G. J. Jr. The lipoprotein-associated coagulation inhibitor that inhibits the factorVII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism ofaction / G. J. Jr. Broze, L. A. Warren, W. F. Novotny, et al. // Blood. — 1988. — Vol.
71.— P. 335–343.176[70] Miller, G. Autoactivation of Human Hageman Factor (Factor XII) / G. Miller, M. Silverberg,A. Kaplan // Biochem. Biophys. Res. Commun. — 1980. — Vol. 92, no. 3. — P. 803–810.[71] Samuel, M. Human Factor XII (Hageman Factor) Autoactivation by Dextran Sulfate /M.
Samuel, R. Pixleys, M. Villanuevas, et al. // J. Biol. Chem. — 1992. — Vol. 267,no. 27. — P. 19691–19697.[72]Терентьева, В. А. Биофизические механизмы контактной активации свертывания плазмы крови / В. А. Терентьева, А. Н. Свешникова, М. А. Пантелеев // Биофизика (принято в печать).[73]Asmis, L. M. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII /L.
M. Asmis, I. Sulzer, M. Furlan, B. Lämmle // Thromb. Res. — 2002. — Vol. 105,no. 6. — P. 463–470.[74] Wiggins, R. C. Role of high-molecular-weight kininogen in surface-binding and activationof coagulation Factor XI and prekallikrein / R. C. Wiggins, B.
N. Bouma, C. G. Cochrane,J. H. Griffin // Proc. Natl. Acad. Sci. USA. — 1977. — Vol. 74, no. 10. — P. 4636–4640.[75] Vogler, E. Contact activation of blood plasma coagulation: A contribuition from the hematology at biomaterial interferances / E. Vogler, C. Siedlecki // Biomaterials. — 2010. —Vol. 30, no. 10. — P. 1857–1869.[76] McMillin, C. R. The secondary structure of human Hageman factor (factor XII) and itsalteration by activating agents / C. R.
McMillin, H. Saito, O. D. Ratnoff, A. G. Walton //J. Clin. Invest. — 1974. — Vol. 54. — P. 1312–1322.[77] Renne, T. Defective thrombus formation in mice lacking coagulation factor XII / T. Renne,M. Pozgajova, S. Gruner, et al. // J. Exp. Med. — 2005. — Vol. 202, no. 2. — P. 271–281.[78] Pham, M. Blood coagulation factor XII-a neglected player in stroke pathophysiology /M.
Pham, G. Stoll, B. Nieswandt, et al. // J. Mol. Med. — 2012. — Vol. 90. —P. 119–126.[79] Dunster, J. L. Mathematical modelling of thrombin generation: asymptotic analysis andpathway characterization / J. L. Dunster, J. R. King // IMA J. Appl. Math. — 2017. —Vol.
82, no. 1. — P. 60–96.177[80] Orfeo, T. The tissue factor requirement in blood coagulation / T. Orfeo, S. Butenas,K. E. Brummel-Ziedins, K. G. Mann // J. Biol. Chem. — 2005. — Vol. 280, no. 52. —P. 42887–42896.[81] Orfeo, T. The nature of the stable blood clot procoagulant activities / T. Orfeo,K. E. Brummel-Ziedins, M. Gissel, et al. // J. Biol. Chem.
— 2008. — Vol. 283,no. 15. — P. 9776–9786.[82] Levine, S. N. Enzyme amplifi er kinetics / S. N. Levine // Science. — 1966. — Vol. 152.— P. 651–653.[83] Khanin, M. A. A mathematical model of the kinetics of blood coagulation / M. A. Khanin,V. V. Semenov // J. Theor. Biol. — 1989. — Vol. 136. — P. 127–134.[84] Khanin, M. A. Mathematical model of the kinetics of platelets and plasma hemostasis systeminteraction / M. A. Khanin, V.
L. Leytin, A. P. A. Pop // Thromb. Res. — 1991. — Vol. 64.— P. 659–666.[85] Семенов, В. В. Нелинеийные эффекты в кинетике гемокоагуляции / В. В. Семенов,М. А. Ханин // Биофизика. — 1990. — Т. 35. — С. 139–141.[86] Jesty, J. Mathematical analysis of a proteolytic positive-feedback loop: dependence of lagtime and enzyme yields on the initial conditions and kinetic parameters / J. Jesty, E.
Beltrami, G. Willems // Biochemistry. — 1993. — Vol. 32. — P. 6266–6274.[87] Beltrami, E. Mathematical analysis of activation thresholds in enzyme-catalyzed pos- itivefeedbacks: application to the feedbacks of blood coagulation / E. Beltrami, J. Jesty // Proc.Natl.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
